3rd Circuit: Amiodarone Warning Claims Are Preempted By Federal Duty Of Sameness
PHILADELPHIA — The Third Circuit U.S. Court of Appeals on July 24 sidestepped a question about whether a generic drugmaker adequately warned about the risks of the heart drug amiodarone under...To view the full article, register now.
Already a subscriber? Click here to view full article